MYRIAD GENETICS INC Quarterly Interest Expense in USD from Q4 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Myriad Genetics Inc quarterly/annual Interest Expense history and growth rate from Q4 2015 to Q1 2024.
  • Myriad Genetics Inc Interest Expense for the quarter ending March 31, 2024 was $500K, unchanged year-over-year.
  • Myriad Genetics Inc Interest Expense for the twelve months ending March 31, 2024 was $2.9M, a 3.57% increase year-over-year.
  • Myriad Genetics Inc annual Interest Expense for 2023 was $2.9M, a 9.38% decline from 2022.
  • Myriad Genetics Inc annual Interest Expense for 2022 was $3.2M, a 51.5% decline from 2021.
  • Myriad Genetics Inc annual Interest Expense for 2021 was $6.6M, a 41.1% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.9M $500K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $2.9M $900K $0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $2.9M $1M +$200K +25% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $2.7M $500K -$100K -16.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $2.8M $500K -$400K -44.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $3.2M $900K +$400K +80% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $2.8M $800K -$300K -27.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $3.1M $600K -$1.4M -70% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $4.5M $900K -$2.1M -70% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $6.6M $500K -$2.4M -82.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $9M $1.1M -$1.8M -62.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $10.8M $2M -$1.1M -35.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $11.9M $3M +$700K +30.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $11.2M $2.9M +$400K +16% Oct 1, 2020 Dec 31, 2020 10-KT 2021-03-16
Q3 2020 $10.8M $2.9M $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $10.8M $3.1M -$100K -3.13% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $10.9M $2.3M -$900K -28.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $11.8M $2.5M -$900K -26.5% Oct 1, 2019 Dec 31, 2019 10-KT 2021-03-16
Q3 2019 $12.7M $2.9M +$700K +31.8% Jul 1, 2019 Sep 30, 2019 10-KT 2021-03-16
Q2 2019 $12M $3.2M +$2.1M +191% Apr 1, 2019 Jun 30, 2019 10-KT 2021-03-16
Q1 2019 $9.9M $3.2M +$2.7M +540% Jan 1, 2019 Mar 31, 2019 10-KT 2021-03-16
Q4 2018 $7.2M $3.4M +$2.7M +386% Oct 1, 2018 Dec 31, 2018 10-KT 2021-03-16
Q3 2018 $4.5M $2.2M +$1.3M +144% Jul 1, 2018 Sep 30, 2018 10-KT 2021-03-16
Q2 2018 $3.2M $1.1M -$100K -8.33% Apr 1, 2018 Jun 30, 2018 10-K 2019-08-13
Q1 2018 $3.3M $500K -$1M -66.7% Jan 1, 2018 Mar 31, 2018 10-K 2019-08-13
Q4 2017 $4.3M $700K -$1.9M -73.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-08-13
Q3 2017 $6.2M $900K +$200K +28.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-08-13
Q2 2017 $6M $1.2M Apr 1, 2017 Jun 30, 2017 10-K 2018-08-24
Q1 2017 $1.5M Jan 1, 2017 Mar 31, 2017 10-K 2018-08-24
Q4 2016 $2.6M +$2.5M +2500% Oct 1, 2016 Dec 31, 2016 10-K 2018-08-24
Q3 2016 $700K Jul 1, 2016 Sep 30, 2016 10-K 2018-08-24
Q4 2015 $100K Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.